Mail.com: Novartis AG https://www.mail.com/companies/42116-novartis-ag.html Mail.com - the best personalized free web-based Email en en Mail.com: Novartis AG https://s.uicdn.com/mailint/8.812.0/assets/mailcom_logo_rss.png https://www.mail.com/companies/42116-novartis-ag.html FDA OKs new Novartis drug for type of advanced breast cancer https://www.mail.com/scitech/health/5033436-fda-oks-novartis-drug-type-advanced-breast-cancer.html TRENTON, N.J. (AP) — U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer. The drug, called Kisqali and developed by Swiss drugmaker Novartis AG, is a pill that works to slow the spread of cancer by blocking two proteins that can stimulate growth and division of cancer cells. ... Mon, 13 Mar 2017 23:28:00 GMT https://www.mail.com/scitech/health/5033436-fda-oks-novartis-drug-type-advanced-breast-cancer.html 2017-03-13T23:28:00Z Gene therapy to fight a blood cancer succeeds in major study https://www.mail.com/scitech/health/4999980-gene-therapy-to-fight-blood-cancer-succeeds-major.html An experimental gene therapy that turns a patient's own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, its maker said Tuesday. In all, 82 percent of patients had their cancer shrink at least by half at some point in the study. ... Tue, 28 Feb 2017 13:16:00 GMT https://www.mail.com/scitech/health/4999980-gene-therapy-to-fight-blood-cancer-succeeds-major.html 2017-02-28T13:16:00Z